MYCN and neuroblastoma: NB risk-classification, established by the International Neuroblastoma Risk Group (INRG), is based on precise prognostic factors (INRG stage, age at diagnosis, histologic category, grade of tumor differentiation, MYCN alterations, 11q aberrations and ploidy) and delineates pretreatment risk-groups [31].